Interestingly, Id3 expression was increased after TPA treatment, whereas it was decreased after U0126 treatment, indicating that ERK/MAPK pathway could induce the expression of Id3 in ESCC cells (Fig. 7F). The gene discussed is ID3; the disease is esophageal squamous cell carcinoma.